Studying a New Treatment for Chronic Knee and Back Pain

Steven Venegas, DPT, Senior Physical Therapist, Mount Sinai Beth Israel, calibrates pods on the bottom of specially designed biomechanical shoes for a patient.

Steven Venegas, DPT, Senior Physical Therapist, Mount Sinai Beth Israel, calibrates pods on the bottom of specially designed biomechanical shoes for a patient.

“We are very excited about introducing AposTherapy to treat chronic knee and back pain,” says Joseph E. Herrera, DO, Chair of the Department of Rehabilitation Medicine. Developed in Israel, AposTherapy uses specially designed biomechanical shoes to retrain the muscles around the knee by adjusting the center of pressure when walking. By changing the foot’s point of contact with the ground, the device shifts the line of force closer to the center of the knee. Pods on the bottom of the shoes are calibrated for each patient by a specially trained physical therapist. Patients wear the shoes for up to two hours a day during their regular activities. The AposTherapy treatment  is being offered as part of a study being conducted at Mount Sinai. The study has enrolled 73 patients. To learn more, visit mountsinai.org/apos or email RehabBIappt@chpnet.org.

Dr. Herrera is a non-paid member of the Medical Advisory Board of AposTherapy.

Early Skin Cancer Screening Minimizes Complications

Aspen-Ideas-Festival- IMG_3030

Melinda Sacks receives a skin cancer screening from Morgan Rabach, MD, Clinical Instructor, Icahn School of Medicine at Mount Sinai.

When Melinda Sacks joined hundreds of other attendees at the 2014 Aspen Ideas Festival, in Aspen, Colorado, to receive a complimentary skin cancer screening by dermatologists at the Mount Sinai Health System, the clinician told her she had a suspicious spot on her face that should be checked by a specialist as soon as she returned home to Stanford, California.

Ms. Sacks says she was surprised by this because “I thought it was a birth mark.” But the small pigmented spot with a clearly defined edge was a lentigo maligna—an early form of melanoma, in which the malignant cells are confined to the tissue of origin. By catching the disease at an early stage, Ms. Sacks was able to have it removed without further complications. (more…)

Mount Sinai Queens Heralds a New Era of Community Health Care with Opening of Ambulatory Pavilion

Ambulance_038.jpg

From left: Darren Fitzpatrick, MD; Ugo Ezenkwele, MD; Brian Radbill, MD, FACP; and Fernando C. Carnavali, MD, at the Mount Sinai Queens Ambulatory Pavilion

Against a backdrop of an evolving national health care system increasingly focused on preventive medicine, outpatient surgical procedures, and other efforts to keep people healthy and out of the hospital, Mount Sinai Queens has opened the doors to its new Ambulatory Pavilion, a $175 million facility that allows it to better serve the health needs of its community and significantly expands its medical and surgical capabilities.

Mount Sinai Queens is located in the heart of Astoria and serves the communities of Western Queens and beyond. With the addition of the Ambulatory Pavilion and continued expansion, it is positioning itself to care for more patients and extend its geographical reach throughout New York City’s largest borough. (more…)

U.S. Surgeon General Visits Mount Sinai Beth Israel’s Model Opioid Treatment Program Facility

MtSinai_160417_SurgeonGeneral_134-RT

The U.S. Surgeon General, Vice Admiral Vivek H. Murthy, MD, MBA, greets patient Gloria Harrison as other patients look on.

The United States Surgeon General, Vice Admiral Vivek H. Murthy, MD, MBA, recently visited Mount Sinai Beth Israel’s Opioid Treatment Program at East 125th Street, one of the hospital’s 11 licensed addiction treatment clinics, to get a first-hand view of a facility that is successfully addressing the nationwide opioid epidemic. Mount Sinai’s model opioid treatment program was among the sites recommended to Dr. Murthy by the New York City Department of Health and Mental Hygiene. (more…)

The 411 on GMOs

Guest post by Jennifer Markowitz MS RD, a Clinical Dietitian in the Nutrition Department at The Mount Sinai Hospital.

Genetically modified organisms are foods or animals produced via gene manipulation. The result of genetic modification is an organism that contains a combination of genes from plants, animals, or bacteria. The most common food GMOs in the U.S. include soy, cotton, canola, corn, sugar beets, Hawaiian papaya, alfalfa, and zucchini. GMOs, however, may also be present in ingredients such as xanthan gum, sweeteners, and natural and artificial flavorings that are commonly found in processed foods. (more…)

Interstitial Lung Disease (ILD)

imageimageGuest post co-written by Maria Padilla, MD, Professor of  Pulmonary, Critical Care, and Sleep Medicine Divison at the Icahn School of Medicine at Mount Sinai, and Aditi Mathur, MD, Assistant Professor of Pulmonary, Critical Care, and Sleep Medicine Division at the Icahn School of Medicine at Mount Sinai.

 

“So, I have been told I have ILD” what does this mean? How do I live with it? What do I do next? (more…)